SCHEMBL3397440

SCHEMBL3397440

Cc1cccc(-c2nnc3n2-c2ccccc2CCC3C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 6/20 0.43
TNKS O95271 4/20 0.43
AVPR1A P37288 2/20 0.40
TACR3 P29371 3/20 0.39
KCNH2 Q12809 2/20 0.39
ERG P11308 1/20 0.39
CCR1 P32246 1/20 0.36
CCR8 P51685 1/20 0.36
MAP3K5 Q99683 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
TACR2 P21452 1/20 0.34
TACR1 P25103 1/20 0.34
CYP2C19 P33261 1/20 0.34
TSHR P16473 1/20 0.34
BRD4 O60885 1/20 0.33
P2RX7 Q99572 2/20 0.33
APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347704 0.85 TNKS2 (0.38) TNKS2TNKSAVPR1ATACR3KCNH2
SCHEMBL1347781 0.85 AVPR1A (0.44) TNKS2TNKSAVPR1ATACR3KCNH2
SCHEMBL3395958 0.83 HSD11B1 (0.36) TNKS2TNKSAVPR1ATACR3KCNH2
SCHEMBL1347857 0.83 TUBB4A (0.37) TNKS2TNKSAVPR1AAPLNR
SCHEMBL3398444 0.76 SMN1; SMN2 (0.48) TNKS2TNKSAVPR1ATACR3CCR1
SCHEMBL3399961 0.76 TNKS2 (0.39) TNKS2TNKSAVPR1ATACR3KCNH2
SCHEMBL3226167 0.71 TNKS2 (0.37) TNKS2TNKSTACR3KCNH2ERG
SCHEMBL1347208 0.70 TNKS2 (0.36) TNKS2TNKSTACR3P2RX7
SCHEMBL12654553 0.70 TNKS2 (0.39) TNKS2TNKSTACR3KCNH2ERG
SCHEMBL24193982 0.70 RIPK1 (0.45) AVPR1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111403-B1 TRIAZABENZO[E]AZULENE DERIVATIVES FOR THE TREATMENT OF TUMORS MERCK PATENT GMBH (DE) 2010-11-10 EP claimed
EP-2111403-B1 TRIAZABENZO[E]AZULENE DERIVATIVES FOR THE TREATMENT OF TUMORS MERCK PATENT GMBH (DE) 2010-11-10 EP disclosed